Application of Atropurpuran derivative composition in anti-hepatic-fibrosis medicine
CN106344570A
Application of Atropurpuran derivative composition in medicine for treating or preventing renal fibrosis
CN106344571A
Application of Atropurpuran derivative composition in medicine resistant to acute renal failure
CN105796561A
Application of composition of piperazine-based and imidazole-based derivatives of virosaine A in rhinitis-resistant medicine
CN105853431A
Composition of piperazine and imidazole based derivatives of Virosaine A and application of composition in drugs for preventing and controlling liver injury
CN105853435A
Application of composition of pyrrolidine derivative and morpholinyl derivative of Virosaine A to anti-inflammatory medicine
CN105853430A
Application of composition of piperazine and imidazole based derivatives of Virosaine A in preparation of drugs against red blood cell hypoplastic anemia
CN105853429A
Application of composition of piperazine and imidazole based derivatives of Virosaine A in preparation of anti-osteoporosis drugs
CN105853438A
Application of composition of pyrrolidine derivative and morpholinyl derivative of Virosaine A to anti-hypoxic medicine
CN105998001A
Application of composition of Salviskinone A benzimidazolyl and di(2-methylmercapto ethyl)amido derivatives in antibacterial drugs
CN105997997A
Application of composition of Salviskinone A derivatives in anti-inflammatory drugs
CN105998008A
Application of composition of Salviskinone A derivatives in anti-acute gout drugs
CN105997996A
Application of composition of Salviskinone A derivatives in drugs for preventing and treating liver injury
CN105998007A
Application of composition of Salviskinone A derivatives in anti-chronic obstructive pulmonary disease drugs
CN105997995A
Application of composition of Salviskinone A derivatives in drugs for increasing leukocytes
CN105998003A
Application of composition of Salviskinone A benzimidazolyl and di(2-methylmercapto ethyl)amido derivatives in drugs for preventing or treating pancreas fibrosis
CN105998005A
Application of composition of Salviskinone A benzimidazolyl and di(2-methylmercapto ethyl)amido derivatives in anti-hypoxic drugs
CN105998010A
Application of composition of Salviskinone A derivatives in anti-low red blood cell anemia drugs
CN105998004A
Application of composition of Salviskinone A benzimidazolyl and di(2-methylmercapto ethyl)amido derivatives in anti-heart failure drugs
CN105998009A
Application of composition of Salviskinone A benzimidazolyl and di(2-methylmercapto ethyl)amido derivatives in anti-rhinitis drugs
